Key result
The use of levosimendan in patients with multifocal atherosclerosis and reduced LVEF undergoing CABG improved central hemodynamical parameters and reduced the length of intensive care unit stay.
Why the study?
Does levosimendan with or without intra-aortic balloon counterpulsation improve hemodynamics and clinical outcomes in patients with multifocal atherosclerosis and reduced LVEF undergoing coronary bypass surgery?
Cohort (n=61)
Does levosimendan with or without intra-aortic balloon counterpulsation improve hemodynamics and clinical outcomes in patients with multifocal atherosclerosis and reduced LVEF undergoing coronary bypass surgery?
In patients with multifocal atherosclerosis and reduced LVEF undergoing CABG, levosimendan improves hemodynamics and reduces ICU stay.
Objective: to optimize preoperative preparation of patients with multifocal atherosclerosis and reduced baseline left ventricular ejection fraction for coronary bypass surgery, by providing a rationale for the use of mechanical and medical circulatory support methods. Subjects and methods. Sixty-one patients with multifocal atherosclerosis, coronary heart disease (CHD), and reduced baseline left ventricular ejection fraction, who underwent coronary bypass surgery, were examined. Levosimendan was administered to 2 groups of patients: 1) 28 patients with preoperative intra-aortic balloon counterpulsation; 2) as inotropic support in 33 patients. There were central and intracardiac hemodynamic changes as evidenced by transpulmonary thermodilution and pulsed Doppler ultrasound echocardiog-raphy during different preoperative preparations. Conclusion. The use of levosimendan in patients with multifocal atherosclerosis, CHD, and planned coronary bypass surgery, by taking into account contraindications to intra-aor-tic balloon counterpulsation, makes it possible to improve central hemodynamical parameters and to reduce the degree of diastolic dysfunction, the incidence of organ dysfunctions, and the length of intensive care unit stay.
No takes yet. Share an insight, caveat, or question.
Grigoryev et al. (2011) conducted a cohort in Multicenter atherosclerosis, coronary heart disease, and reduced baseline left ventricular ejection fraction (n=61). Levosimendan with preoperative intra-aortic balloon counterpulsation vs. Levosimendan as inotropic support alone was evaluated on Central and intracardiac hemodynamic changes. The use of levosimendan in patients with multifocal atherosclerosis and reduced LVEF undergoing CABG improved central hemodynamical parameters and reduced the length of intensive care unit stay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: